A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
NCT05445895 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 483
Last updated 2025-11-21
Summary
A study to Evaluate the Efficacy and Safety of Renexin CR in patients with Acute Non-cardioembolic Ischemic Stroke
Conditions
Interventions
- DRUG
-
Renexin CR 200/160mg
Renexin CR 200/160mg will be added to Aspirin 100mg
- DRUG
-
Plavix 75mg
Plavix 75mg will be added to Aspirin 100mg
Sponsors & Collaborators
-
SK Chemicals Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-16
- Primary Completion
- 2025-10-02
- Completion
- 2025-11-07
Countries
- South Korea
Study Locations
More Related Trials
-
Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study
NCT02784717 ·Status: COMPLETED
-
The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke
NCT01684462 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
NCT01208233 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke
NCT02828540 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke
NCT05585606 ·Status: COMPLETED ·Phase: PHASE2
-
Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke
NCT02643784 ·Status: UNKNOWN ·Phase: PHASE4
-
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
NCT03578822 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
NCT07279493 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy
NCT05836753 ·Status: UNKNOWN ·Phase: PHASE2
-
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
NCT06396858 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
NCT02042534 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
NCT04504864 ·Status: UNKNOWN ·Phase: PHASE4
-
PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy
NCT07174375 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation
NCT03746301 ·Status: COMPLETED
-
Effect of Aspirin at the Acute Phase of Cerebral Ischemic Event.
NCT01375400 ·Status: UNKNOWN ·Phase: NA
-
Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial Fibrillation
NCT03284762 ·Status: COMPLETED
-
The PK/PD Study of SHR2285 Tablets in Healthy Subjects
NCT03769831 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT05515393 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke
NCT05836740 ·Status: COMPLETED ·Phase: PHASE3
-
Non-immunogenic Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
NCT05697575 ·Status: RECRUITING
-
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
NCT05691244 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
NCT00494871 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Levofloxacin Combined With Intravenous Thrombolysis for Acute Ischemic Stroke
NCT05741905 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2